Scheme Information Sheets

UK NEQAS for Lipid Investigations

Scheme Particulars Indicative Details
Accreditation body UKAS
ISO/IEC Accreditation status ISO/IEC 17043:2023
UKAS Accredited Proficiency Testing Provider No 7860
Objective of Scheme Provides EQA coverage for a wide range of lipid parameters, including a separate specimen for Lipoprotein (a). The separate specimen allows endogenous material, from a single donor, to be distributed for Lipoprotein (a)
Pre-, Analytical, Post- status Analytical
Number of distributions per year (nominal) 11
Specimens per distribution 3 (Separate specimens for Lp(a))
Number of Specimens per annum 33
Frequency of distribution Monthly
Scoring system ABC
Material distributed Pooled, liquid human serum with or without exogenous added analyte
Programme Director(s) / Organiser(s) Finlay MacKenzie
Criteria for participation All, but overseas by courier
Nominal sample volume (mL) 0.5
Sample presentation TACs Lipoprotein (a) is in a separate tube to the other Lipid analytes
Data in Chemistry on-line Dashboard Yes
Analyte Approx Range Default Units Target Value B Score Limit (%) C Score Limit (%)
Apo A1 0.4 – 4 g/L ALTM 7.5 10.0
Apo B 0.2 – 2 g/L ALTM 7.5 10.0
HDL cholesterol 0.4 – 4 mmol/L MLTM 10.0 10.0
Homocysteine 10 – 50 µmol/L ALTM 10.0 15.0
LDL cholesterol 1 – 5 mmol/L MLTM 10.0 10.0
Lp(a) 30 – 500 nmol/L ALTM 50.0 40.0
non-HDL cholesterol 1 – 7 mmol/L MLTM 10.0 10.0
Total cholesterol 2 – 10 mmol/L MLTM 5.0 5.0
Triglyceride 0.5 – 10 mmol/L MLTM 5.0 7.5
VLDL cholesterol 0 – 2 mmol/L MLTM 10.0 10.0
Abbreviation Expansion
ALTM All Laboratory Trimmed Mean
GLTM Group Laboratory Trimmed Mean – which is the Method Principle Mean
MLTM Method Laboratory Trimmed Mean – usually a manufacturer system / analyser mean
XALTM An external value that may be from a Reference Method System
OGLTM A Method Principle Mean used as the target for all laboratories
OMLTM A specific Method Mean used as a target for all laboratories
MED Median

Last Updated: